Small Cap Stocks to Track: Affimed N.V. (AFMD), Joey New York, Inc. (JOEY), First Majestic Silver Corp. (AG)

Affimed N.V. (NASDAQ:AFMD) gained volume of 2.84 million shares and the average volume of the stock remained 444.43K shares. The 52 week range of the stock remained $1.15 – $2.85 and today’s day range was $2.00 – $2.10. The stock opened the session at $2.05 but then moved to $2.08, at recent check. At that price, the stock was showing a negative performance of -15.31%.

June 15, 2018 — Affimed N.V. (AFMD) presented new interim data from the Phase 1b dose escalation study evaluating AFM13, its lead NK cell engager candidate, at the European Hematology Association (EHA) 23rd Congress in Stockholm. Dr. Eva Domingo of the Instituto Catalán de Oncología L’Hospitalet, Barcelona, Spain, presented the poster, titled A Phase 1 Study Investigating the Combination of AFM13 and the Monoclonal Anti-PD-1 Antibody Pembrolizumab in Patients with Relapsed/Refractory Hodgkin Lymphoma after Brentuximab Vedotin Failure: Updated Safety and Efficacy Data.

Assessment of 18 patients treated at the highest AFM13 dose showed best overall response rate (ORR) of 89% (16/18 patients) and complete metabolic response rate (CmR) of 28% (5/18 patients). The ORR and CmR for these 18 patients compare favorably to those of anti-PD-1 monotherapy in similar patient populations.

Responders included three patients who were either primary refractory to or had relapsed during front-line therapy and were refractory to all subsequent lines of therapy. The combination of AFM13 and pembrolizumab was well tolerated, with most adverse events mild to moderate in nature and manageable with standard of care measures.

Joey New York, Inc. (OTCBB:JOEY) was trading with a volume of 29,252.00 shares versus the average volume of the stock 26,858.00 shares. The stock increased +18.89% and was recently trading at $0.107. The market capitalization of the stock remained 3.36 million.

Joey New York, Inc., through its subsidiary, RAR Beauty, LLC, manufactures and markets natural skin care and beauty products in the United States and Internationally. The company operates through The LABB, Aesthetic Beauty Bar; and Joey New York Cosmetics divisions. The LABB, Aesthetic Beauty Bar division provides injectable services, which eliminate unwanted wrinkles by performing Botox and filler injections. The company offers its products under the Joey New York brand. It offers its products through retailers, professional salons, spas, and beauty Websites.

In the current trading day, First Majestic Silver Corp. (NYSE:AG) decreased -6.40% to move at $7.46. The volume of the stock was 8.46 million shares and the average volume remained 2.61 million shares. The stock, at last check, has the day price range of $7.38 – $7.86. The market capitalization was recorded at 1.23 billion.

First Majestic Silver Corp. (AG) on May 11, 2018 announced that it has terminated the pre-existing silver purchase agreement with Wheaton Precious Metals Corp. (“WPM”) and its subsidiary, Wheaton Precious Metals International Ltd. (“WPMI”), relating to the newly acquired San Dimas Mine and entered into a new precious metal purchase agreement (the “New Stream Agreement”) with WPMI and FM Metal Trading (Barbados) Inc., a wholly-owned subsidiary of First Majestic.

Pursuant to the New Stream Agreement, WPMI will be entitled to receive 25% of the gold production and 25% of the silver production converted to gold equivalent at a fixed exchange ratio of 70:1 at San Dimas in exchange for ongoing payments equal to the lesser of US$600 (subject to a 1% annual inflation adjustment) and the prevailing market price, for each gold ounce delivered to an offtaker under the agreement. As part of the termination of the previous silver purchase agreement, WPMI received 20,914,590 common shares of First Majestic.

The New Stream Agreement provides for a number of value creation opportunities with alignment between silver and gold production and increased post-stream cash flow at San Dimas. First Majestic and WPMI have agreed to fix the gold to silver ratio that will be used to calculate the gold equivalent production at 70:1, with provisions to adjust the gold to silver ratio if the average gold to silver ratio moves above or below 90:1 or 50:1, respectively, for a period of six months.

Previous ArticleNext Article

Related Post

Himax Technologies, Inc. (NASDAQ:HIMX) Technical A... Himax Technologies, Inc. (NASDAQ:HIMX) gained 3.37% in yesterday’s session, going up from its prior closing price of $10.08 to $10.42, and has now rec...
Fundamentals in Focus for Amarin Corporation plc (... Amarin Corporation plc (NASDAQ:AMRN) is an interesting stock at present. Now trading with a market value of 783.87M, the company has a mix of catalyst...
For II-VI Incorporated (IIVI), It May Be As Good A... It is interesting to note that II-VI Incorporated (NASDAQ:IIVI) is active and made a solid movement in the last trading day. Now trading with a market...
The Fundamental Case for and Against HTG Molecular... HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)'s interesting series of developments are underway around the US stock market these days. Now trading wit...
Drilling Down Into the Books for MDC Partners Inc.... MDC Partners Inc. (NASDAQ:MDCA) seems to be forming a pattern of major movements, providing only some crumbs of outlook for market participants trying...